Type 1 diabetes results from the destruction of insulin-producing cells in the pancreas. Individuals with type 1 diabetes produce insufficient amounts of insulin, a hormone that regulates the concentration of glucose in the blood.
Which of the following best explains how treatment with a drug that stimulates the production of insulin receptors on target cells will affect the insulin signaling pathway in an individual with type 1 diabetes?
The drug will have little or no effect on the signaling pathway because the receptors will not be activated in the absence of insulin.